Protective effect of BCG among children vaccinated under Universal Immunization Programme

Indian Journal of Pediatrics

Volumn 71, Issue 12, 2004, Pages 1069-1074

  Chadha, V K ^a,b   Suryanarayana, L ^a   Suryanarayan, H V ^a   Srikantaramu, N ^a   Kumar, P ^a  

^a Nationational Tuberculosis Institute   (India)

^b NATIONAL TUBERCULOSIS INSTITUTE   (India)

Author keywords

BCG; Protective effect; Tuberculosis

Indexed keywords

BCG VACCINE;

ADOLESCENT; ARTICLE; BCG VACCINATION; CASE CONTROL STUDY; CHILD; CHILD HEALTH CARE; CONTROLLED STUDY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INDIA; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; TUBERCULOSIS; VACCINATION;

EID: 12444260640     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02829816     Document Type: Article

References (28)

1. Smith DW, Ernst H, Wiegeshaus and Edwards M L. The protective effects of BCG vaccination against tuberculosis; Mycobacterium Tuberculosis 1988; 341-370.
2. Ten Dam H.G, Pio A. Pathogenesis of tuberculosis and effectiveness of BCG vaccination. Tubercle 1982; 63: 225-233.
3. Ten Dam HG, Hitze KL. Does BCG vaccination protect the newborn and young infants? Bull WHO 1980; 58: 37-41.
4. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E et al. The efficacy of bacillus Calmette-Guerin vaccination of new borns and infants in the prevention of tuberculosis: meta-analysis of the published literature. Pediatrics 1995; 96: 29-35.
5. World Health Organisation, Geneva: WHO report 2003. Global Tuberculosis control - surveillance, planning, financing.
6. Chadha VK, Vaidyanathan PS, Jagannatha PS, Unnikrishnan KP, Savanur SJ, Mini PA. Annual risk of tuberculous infection in the western zone of India. Int J Tuber Lung Dis 2003; 7: 536-542.
7. Chadha VK, Vaidyanathan PS, Jagannatha PS, Unnikrishnan KP, Mini PA. Annual risk of tuberculous infection in the northern zone of India. Bull WHO 2002; 81: 572-581.
8. Kolappan C, Gopi PG, Subramani R, Chadha VK, Kumar P, Prasad V et al. Estimation of annual risk of tuberculous infection among children aged 1-9 years in the south zone of India. Int J Tuber Lung Dis 2004; 8: 418-423.
9. VK Chadha, P. Kumar, Gupta J, PS Jaganath, Magesh V, Singh S et al. Annual risk of tuberculous infection in the eastern zone of India. Int J Tuberc Lung Dis 2004; 8: 537-544.
10. Tuberculosis Prevention Trial, Madras, Trial of BCG vaccines in south India for tuberculosis prevention. Indian J Med Res 1980 (suppl); 72: 1-74.
11. Tuberculosis Research Centre (ICMR), Chennai, Fifteen year follow up of trial of BCG vaccines in South India for tuberculosis prevention. Indian J Med Res 1999; 110: 56-69.
12. Brewer TF. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000; 3: S64-S67.
13. Chadha VK, Jagannatha PS, Suryanarayana HV. Tuberculin sensitivity in BCG vaccinated children and its implication for ARI estimation; Ind J Tub 2000; 47: 139-146.
14. Chadha VK, Jaganath PS, Kumar P. Can BCG vaccinated children be included for tuberculin surveys to estimate annual risk of tuberculous infection in India? Int J Tuberc Lung Dis.
15. Stegen G, Kenneth Jones, Patricia Kaplan. Criteria for guidance in the diagnosis of tuberculosis. Pediatrics 1969; 260-263.
16. Chakraborty AK, Ganapathy KT, Rajalakshmi R. Effect of Nutritional status on delayed hypersensitivity due to tuberculin test in children of an urban slum community. Indian J Tuberc 1980; 116-119.
17. Smith PG. Retrospective assessment of the effectiveness of BCG vaccination against tuberculosis using the case control method. Tubercle 1982; 23-35.
18. Clemens JD, Jackie Chuong JH, Alvan R, Feinstein. The BCG Controversy - A methodological and statistical reappraisal. J Med Assoc 1983; 249.
19. Altet Gomez MN, Alcaide Megias J, Canela Soler J, Serra Majen L. Salleras Sanmarti L, Retrospective evaluation of the efficacy of the BCG vaccination campaign of newborns in Barcelona, Spain. Tubercle 1993; 74: 100-105.
20. Kotb MM, Azza AT. Evaluation of the efficacy of routine BCG vaccination. A case control study. J Egypt Pub Health Assoc 1993; 469-485.
21. Padungchan S, Konjanart, Kasiratta S, Daramas S, Ten Dam H.G. The effectiveness of BCG vaccination of the new born against childhood tuberculosis in Bangkok. Bull WHO 1986; 64 : 247-258.
22. Tidjani O, Amedome A, Ten Dam HG. The protective effect of BCG vaccination of the new born against childhood tuberculosis in an African community. Tubercle 1986; 67: 269-281.
23. Young T, Hershfield E. A case control study to evaluate effectiveness of mass BCG vaccination among Canadian Indians. Am J Pub Health 1986; 76: 783-786.
24. al-Kassimi FA, al-Hajjaj MS, al-Orainey IO, Bamgboye EA. Does the protective effect of neonatal BCG correlate with vaccine induced tuberculin reaction? Am J Respir Crit Care Med 1995; 152: 1575-1578.
25. Fillo VW, Castilho de EA, Rodrigues LC, Huttley SRA. Effectiveness of BCG against tuberculous meningitis. A case control study in Sao Paulo, Brazil. Bull WHO 1990; 68: 69-74.
26. Romanus V, Sweedish experiences 12 years after the cessation of general BCG vaccination of new borns in 1975. Bull Int Un TB Lung Dis 1988; 63: 34-38.
27. Kelly P, Mc Keown D, Clancy L. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis. Eur Respir J 1997; 10(3): 619-623.
28. Zhang LX, Tu DH, He GX, Ma ZQ, Nagelkerke NJ, Borgdorff MW et al. Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette - Guerin in Beijing. Am J Respir Crit Care Med 2000; 162: 1314-1317.